Acute cerebral infarction
Conditions
Interventions
Sponsors
Department of Encephalopathy, Tianjin Beichen District Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Cranial imaging: Ct showed no hemorrhage. Brain Mr Showed high DWI signal. No abnormalities were found with T2 t2FLAIR; 2. The patient meets the diagnostic criteria of stroke in Chinese medicine and has the main symptoms mentioned above; 3. Aged 40 to 80 years; 4. Acute onset, onset time < 4.5 hours; 5. Patients with moderate and moderate to severe stroke who scored 4-20 points; 6. There was no significant difference in VAS scores; 7. Blood routine, coagulation function, liver and kidney function were all normal; 8. Obtain informed consent.
Exclusion criteria
Exclusion criteria: 1. Suspected subarachnoid hemorrhage; 2. A history of intracranial hemorrhage; 3. There are intracranial tumors, arteriovenous malformations, and aneurysms; 4. A history of major head trauma or cerebral infarction in the last 3 months; In the last 1 week, artery puncture occurred in the area not easy to compress hemostasis; 5. Recent intracranial or intraspinal surgery; 6. Blood glucose 180mmhg, or diastolic bp > 110mmhg; 7. Patients with severe heart, liver, renal insufficiency or severe diabetes; 8. With active bleeding; 9. Acute bleeding tendency: Including platelet counts below 100*109/ L or other conditions; Oral anticoagulant, and inr > 1.7 or pt > 15s; Heparin treatment within 48 h (APTT beyond normal range)Direct thrombin or factor XA inhibitors are currently being used, And sensitive laboratory indicators(Such as APTT, INR, Platelet count, Snake vein enzyme coagulation time, Thrombin time or appropriate factor XA activity determination); 10. Ct suggested a low-density range greater than 1/3 of the cerebral hemisphere; 11. A pregnant or lactating woman; 12. Allergic constitution(Allergic to more than 2 kinds of food or drugs); 13. Known to be allergic to this drug and RTPA; 14. Have participated in other drug trials within 2 months; 15. The physician determines that the participant cannot or may not be able to complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIHSS;Barthel; | — |
Secondary
| Measure | Time frame |
|---|---|
| CRP and FIB; | — |
Countries
China
Contacts
Public ContactYinghong Li
Department of Encephalopathy, Tianjin Beichen District Hospital of Traditional Chinese Medicine
Outcome results
None listed